On the stock market since 2019, it operates in the world of health and science. Now — the numbers.
This is an established company with proven profits.
Average growth of 48% a year over the last 4 years. Red columns mark years that ended in a loss.
If every debt were paid off today, $3.9M would still be left in the vault — a solid cushion for hard times.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
Over the last 3 years, sales grew about 52% a year on average.
There is $3.9M in the vault; even if every debt were paid off, $3.9M would remain.
The price action doesn’t yet back an upward turn. Council score: 0/10.
On our five-subject report card, ASRPF sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: ASRPF is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.